MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.-MedSci.cn

MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.

Ly, I; Cardona, J; Lou, K; Beers, A; Chang, K; Brown, J; Reardon, DA; Arrillaga-Romany, I; Forst, DA; Jordan, JT; Lee, EQ; Dietrich, J; Nayak, L; Wen, PY; Chukwueke, UN; Batchelor, T; Curry, WT; Kalpathy-Cramer, J; Gerstner, ER

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

科室
- - 订阅+
  - 更多科室
工具
服务